What did the FDA say about Breast Implant Illness (BII)?

Robert Whitfield MDAmerica's Breast Implant Illness Expert™

Is Breast Implant Illness Real? The FDA's Controversial Stance

18 Dec 2024 · 1 min

Watch on YouTube

0:31

This YouTube video (created/posted by Robert Whitfield MD on December 18, 2024) discusses Breast Implant Illness (BII) and the FDA’s position. Early in the video the FDA is quoted as saying BII is not recognized as a formal medical diagnosis and that there are no specific tests or recognized criteria to define it; the speaker (Mark/Robert Whitfield MD) replies that he views BII as a chronic inflammatory process linked to breast implants, which may persist even after implant removal and can become a chronic inflammatory condition.

Questions this video answers

The FDA said BII "is not recognized as a formal medical diagnosis, and there are no specific tests or recognized criteria to define or characterize it."

Chapters

FDA said, quote BII Breast implant illness is not recognized as a formal medical diagnosis, and there are no specific tests or recognized criteria to define or characterize it. Mark, do you agree with that? Breast implant illness, to me, is a chronic inflammatory process of which the medical device, in this case a breast implant, is a component. And when you take it out, you don't resolve that process completely. But if the signal never turns off, eventually it becomes a chronic inflammatory.